MicroRNA-21 promotes oral cancer invasion via the wnt/β-catenin pathway by targeting DKK2

Pathology and Oncology Research

Volumn 20, Issue 2, 2014, Pages 253-261

  Kawakita, Akiko ^a   Yanamoto, Souichi ^a   Yamada, Shin Ichi ^a   Naruse, Tomofumi ^a   Takahashi, Hidenori ^a   Kawasaki, Goro ^a   Umeda, Masahiro ^a  

^a NAGASAKI UNIVERSITY GRADUATE SCHOOL OF BIOMEDICAL SCIENCES   (Japan)

Author keywords

DKK2; MiR 21; Oral tongue squamous cell carcinoma; Tumor invasion; catenin

Indexed keywords

BETA CATENIN; LOCKED NUCLEIC ACID; MICRORNA 21; WNT PROTEIN; DKK2 PROTEIN, HUMAN; MICRORNA; MIRN21 MICRORNA, HUMAN; SIGNAL PEPTIDE;

AGED; ARTICLE; CARCINOMA CELL; CELL ASSAY; CELL INVASION; CELL STRAIN; CELL STRAIN SCC25; CONTROLLED STUDY; DICKKOPF 2 GENE; DOWN REGULATION; FACTORIAL ANALYSIS; FEMALE; GENE; GENE FUNCTION; GENE OVEREXPRESSION; GENE SILENCING; GENETIC ASSOCIATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; IN VITRO STUDY; MAJOR CLINICAL STUDY; MALE; MOUTH SQUAMOUS CELL CARCINOMA; NUCLEIC ACID PROBE; PHENOTYPE; PREDICTION; PRIMARY TUMOR; PROTEIN RNA BINDING; TUMOR INVASION; UPREGULATION; WESTERN BLOTTING; CELL MOTION; CELL PROLIFERATION; GENE EXPRESSION REGULATION; GENETICS; MOUTH TUMOR; PATHOLOGY; TUMOR CELL LINE;

AGED; BETA CATENIN; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MICRORNAS; MOUTH NEOPLASMS; NEOPLASM INVASIVENESS; UP-REGULATION; WNT PROTEINS;

EID: 84898796271     PISSN: 12194956     EISSN: 15322807     Source Type: Journal    
DOI: 10.1007/s12253-013-9689-y     Document Type: Article

References (37)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D (2011) Global cancer statistics 2011. CA Cancer J Clin 61:69-90
2. Warnakulasuriya S (2009) Global epidemiology of oral and oropharyngeal cancer. Oral Oncol 45:309-316
3. Rogers NS, Brown SJ, Woolgar AJ, Lowe D, Magennis P, Shaw JR, Sutton D, Errington D, Vaughan D (2009) Survival following primary surgery for oral cancer. Oral Oncol 45:201-211
4. Yanamoto S, Kawasaki G, Yoshitomi I, Mizuno A (2002) P53, mdm2, and p21 expression in oral squamous cell carcinomas: relationship with clinicopathologic factors. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 94:593-600
5. Sessions GD, Lenox J, Spector JG, Chao C, Chaudry AO (2003) Analysis of treatment results for base of tongue cancer. Laryngoscope 113:1252-1261
6. Kurokawa H, Zhang M, Matsumoto S, Yamashita Y, Tomoyose T, Tanaka T, Fukuyama H, Takahashi T (2005) The high prognostic value of the histologic grade at the deep invasive front of tongue squamous cell carcinoma. J Oral Pathol Med 34:329-333
7. Bryne M, Koppang SH, Lilleng R, Kjaerheim A (1992) Malignacy grading of the deep invasive margins of oral squamous cell carcinoma has high prognostic value. J Pathol 166:375-381
8. Bryne M, Jenssen N, Boysen M (1995) Histologic grading in the deep invasive front of T1 and T2 glottic squamous cell carcinomas has high prognostic value. Virchows Arch 427:277-281
9. Bartel PD (2004) MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116:281-297
10. Hannon JG, Rossi JJ (2004) Unlocking the potential of the human genome with RNA interference. Nature 431:371-378
11. Esquela-Kerscher A, Slack JF (2006) Oncomirs-microRNAs with a role in cancer. Nat Rev Cancer 6:259-269
12. Calin AG, Croce MC (2006) MicroRNA signatures in human cancers. Nat Rev Cancer 6:857-866
13. Wu HB, Xiong PX, Jia J, Zhang FW (2011) MicroRNAs: new actors in the oral cancer scene. Oral Oncol 47:314-319
14. Volinia S, Calin AG, Liu GC, Ambs S, Cimmino A, Petrocca F, Visone R, Iorio M, Roldo C, Ferracin M, Prueitt LR, Yanaihara N, Lanza G, Scarpa A, Vecchione A, Negrini M, Harris CC, Croce MC (2006) A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci USA 103:2257-2261
15. Krichevsky MA, Gabriely G (2009) MiR-21: a small multi-faceted RNA. J Cell Mol Med 13:39-53
16. Fu X, Han Y, Wu Y, Zhu X, Lu X, Mao F, Wang X, He X, Zhao Y, Zhao Y (2011) Prognostic role of microRNA-21 in various carcinomas: a systematic review and meta-analysis. Eur J Clin Invest 41:1245-1253
17. Yan XL, Huang FX, Shao Q, Huang YM, Deng L, Wu LQ, Zeng XY, Shao YJ (2008) MicroRNA miR-21 overexpression in human breast cancer is associated with advanced clinical stage, lymph node metastasis and patient poor prognosis. RNA 14:2348-2360
18. Hwang HJ, Voortman J, Giovannetti E, Steinberg MS, Leon GL, Kim YT, Funel N, Park KJ, Kim AM, Kang HG, Kim WS, Del Chiaro M, Peters JG, Giaccone G (2010) Identification of microRNA-21 as a biomarker for chemoresistance and clinical outcome following adjuvant therapy in resectable pancreatic cancer. PLoS ONE 5:e10630
19. Asangani AI, Rasheed AS, Nikolova AD, Leupold HJ, Colburn HN, Post S, Allgayer H (2008) MicroRNA-21 (miR-21) post-transcriptionally downregulates tumor suppressor Pdcd4 and stimulates invasion, intravasation and metastasis in colorectal cancer. Oncogene 27:2128-2136
20. Reis PP, Tomenson M, Cervigne KN, Machado J, Jurisica I, Pintilie M, Sukhai AM, Perez-Ordonez B, Grenman R, Gilbert WR, Gullane JP, Irish CJ, Kamel-Reid S (2010) Programmed cell death 4 loss increases tumor cell invasion and is regulated by miR-21 in oral squamous cell carcinoma. Mol Cancer 9:238
21. Zhang GB, Li FJ, Yu QB, Zhu GZ, Liu YB, Yan M (2012) MicroRNA-21 promotes tumor proliferation and invasion in gastric cancer by targeting PTEN. Oncol Rep 27:1019-1026
22. Han L, Yue X, Zhou X, Lan MF, You G, Zhang W, Zhang LK, Cheng QJ, Yu ZS, Pu YP, Jiang T, Kang SC (2012) MicroRNA-21 expression is regulated by β-catenin/STAT3 pathway and promotes glioma cell invasion by direct targeting RECK. CNS Neurosci Ther 18:573-583
23. Li T, Li SR, Li HY, Zhong S, Chen YY, Zhang MC, Hu MM, Shen JZ (2012) MiR-21 as an independent biochemical recurrence predictor and potential therapeutic target for prostate cancer. J Urol 187:1466-1472
24. Yanamoto S, Kawasaki G, Yoshitomi I, Iwamoto T, Hirata K, Mizuno A (2007) Clinicopathologic significance of EpCAM expression in squamous cell carcinoma of the tongue and its possibility as a potential target for tongue cancer gene therapy. Oral Oncol 43:869-877
25. Li J, Huang H, Sun L, Yang M, Pan C, Chen W, Wu D, Lin Z, Zeng C, Yao Y, Zhang P, Song E (2009) MiR-21 indicates poor prognosis in tongue squamous cell carcinomas as an apoptosis inhibitor. Clin Cancer Res 15:3998-4008
26. Moriyama T, Ohuchida K, Mizumoto K, Yu J, Sato N, Nabae T, Takahata S, Toma H, Nagai E, Tanaka M (2009) MicroRNA-21 modulates biological functions of pancreatic cancer cells including their proliferation, invasion, and chemoresistance. Mol Cancer Ther 8:1067-1074
27. Zheng J, Xue H, Wang T, Jiang Y, Liu B, Li J, Li Y, Wang W, Zhang B, Sun M (2011) MiR-21 downregulates the tumor suppressor p12CDK2AP1 and stimulates cell proliferation and invasion. J Cell Biochem 112:872-880
28. Ren J, Zhu D, Liu M, Sun Y, Tian L (2010) Downregulation of miR-21 modulates Ras expression to promote apoptosis and suppress invasion of laryngeal squamous cell carcinoma. Eur J Cancer 46:3409-3416
29. Liu LZ, Wang H, Liu J, Wang XZ (2013) MicroRNA-21 (miR-21) expression promotes growth, metastasis, and chemo- or radioresistance in non-small cell lung cancer cells by targeting PTEN. Mol Cell Biochem 374:35-45
30. Han M, Liu M, Wang Y, Chen X, Xu J, Sun Y, Zhao L, Qu H, Fan Y, Wu C (2012) Antagonism of miR-21 reverses epithelial-mesenchymal transition and cancer stem cell phenotype through AKT/ERK1/2 inactivation by targeting PTEN. PLoS ONE 7:e39520
31. Krupnik EV, Sharp DJ, Jiang C, Robison K, Chickering WT, Amaravadi L, Brown ED, Guyot D, Mays G, Leiby K, Chang B, Duong T, Goodeari DA, Gearing PD, Sokol YS, MaCarthy AS (1999) Functional and structural diversity of the human Dickkopf gene family. Gene 238:301-313
32. Mao B, Niehrs C (2003) Kremen2 modulates Dickkopf2 activity during Wnt/LRP6 signaling. Gene 302:179-183
33. Zhu J, Zhang S, Gu L, Di W (2012) Epigenetic silencing of DKK2 and Wnt signal pathway components in human ovarian carcinoma. Carcinogenesis 33:2334-2343
34. Hirata H, Hinoda Y, Nakajima K, Kawamoto K, Kikuno N, Kawakami K, Yamamura S, Ueno K, Majid S, Saini S, Ishii N, Dahiya R (2009) Wnt antagonist gene DKK2 is epigenetically silenced and inhibits renal cancer progression through apoptotic and cell cycle pathways. Clin Cancer Res 15:5678-5687
35. Clvers H, Nusse R (2012) Wnt/β-catenin signaling and disease. Cell 149:1192-1205
36. Betel D, Koppal A, Agius P, Sander C, Leslie C (2010) Comprehensive modeling of microRNA targets predicts functional non-conserved and non-canonical sites. Genome Biol 11:R90
37. Yang HC, Yue J, Fan M, Pfeffer ML (2010) IFN induces miR-21 through a signal transducer and activator of transcription 3-dependent pathway as a suppressive negative feedback on IFN-induced apoptosis. Cancer Res 70:8108-8116